Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Co-amoxiclav 125mg/31mg/5ml oral suspension |
| BNF code | 0501013K0AAAHAH |
| Virtual Therapeutic Moiety | Co-amoxiclav |
| Basis of preferred name | BAN - British Approved Name |
| Date of name applicability | 18 Nov 2004 |
| Previous name | Co-amoxiclav 125mg/31mg oral suspension |
| Basis of previous name | BAN - British Approved Name |
| Reason for name change | Other |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Non-availability | Actual Products Available |
| Non-availability status date | 1 Oct 2024 |
| Dose form | Discrete |
| Unit dose form size | 5.000 |
| Unit dose form units | ml |
| Unit dose unit of measure | spoonful |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Amoxicillin trihydrate |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 372687004 |
| Strength value numerator | 25.000 |
| Strength value numerator unit | mg |
| Strength value denominator | 1.000 |
| Strength value denominator unit | ml |
| Virtual Product Ingredient | |
| Ingredient | Potassium clavulanate |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 395939008 |
| Strength value numerator | 6.250 |
| Strength value numerator unit | mg |
| Strength value denominator | 1.000 |
| Strength value denominator unit | ml |
| Ontology Drug Form & Route | |
| Form & Route | suspension.oral |
| Dose Form | |
| Formulation | Oral suspension |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Augmentin 125/31 oral suspension (GlaxoSmithKline UK Ltd) | |
| Co-amoxiclav 125mg/31mg/5ml oral suspension (A A H Pharmaceuticals Ltd) | |
| Co-amoxiclav 125mg/31mg/5ml oral suspension (Alliance Healthcare (Distribution) Ltd) | |
| Co-amoxiclav 125mg/31mg/5ml oral suspension (Almus Pharmaceuticals Ltd) | |
| Co-amoxiclav 125mg/31mg/5ml oral suspension (Colorama Pharmaceuticals Ltd) | |
| Co-amoxiclav 125mg/31mg/5ml oral suspension (Medihealth (Northern) Ltd) | |
| Co-amoxiclav 125mg/31mg/5ml oral suspension (Phoenix Healthcare Distribution Ltd) | |
| Co-amoxiclav 125mg/31mg/5ml oral suspension (Sandoz Ltd) | |
| Virtual Medicinal Product Packs | |
| Co-amoxiclav 125mg/31mg/5ml oral suspension 100 ml | |
dm+d data retrieved from TRUD: release NHSBSA_11.0.0_20251103000001, imported on 4th November 2025 at 04:00:10.